Retatrutide 15mg (30 Day Protocol)

Description

Explore the frontier of metabolic science with our premium Retatrutide 15mg, engineered for advanced research into weight management and metabolic health. As a pioneering triple-agonist (GGG) peptide, Retatrutide acts on three core receptors—GLP-1, GIP, and Glucagon—offering a comprehensive approach to satiety, glucose homeostasis, and energy expenditure.

• Next-Generation Triple-Agonist: Activates GLP-1, GIP, and Glucagon receptors simultaneously for enhanced metabolic modulation.
• Comprehensive Protocol: 15mg potency suitable for 30-day studies exploring significant reduction in body weight and visceral fat.
• High Purity Peptide: Manufactured to strict research standards to ensure consistent study results.
• Enhanced Fat Utilization: Unlike dual agonists, the inclusion of the glucagon receptor pathway specifically allows researchers to study increased energy expenditure.